NEW YORK(GenomeWeb) – OncoDNA announced on Wednesday that it has finalized a South Korean distribution agreement with Eone-Diagnomics Genome Center (EDGC).

Under the terms of the agreement, EDGC will have exclusive distribution rights in South Korea for the OncoDEEP Dx panel and other cancer-related tests. Korean physicians will have access to clinically relevant interpretations of test results using the OncoShare web platform.

The OncoDEEP Dx is a 50-gene next-generation sequencing-based diagnostic test that runs on Life Technologies' Ion Torrent instrument.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.